In our monthly podcast we discuss with Prof Gillian Leng, NICE chief executive, and Marie Burnham, guideline committee chair, why shared decision making is such a vital part of healthcare and the work that went into developing such an important guideline.

Shared decision making: why is it so important?

We speak to Consultant Respiratory Physician Dr Hitasha Rupani, Medicines Consultant Clinical Adviser at NICE Jonathan Underhill and asthma patient Sheba Joseph about NICE’s recently published patient decision aid on asthma inhalers and climate change. The aid supports people with asthma to consider whether they might be able to use inhalers which have a smaller carbon footprint as part of their treatment plan. You can view the patient decision aid by visiting the NICE website: https://bit.ly/3fnLt1K

New patient decision aid on asthma inhalers and climate change

As part of Bowel Cancer Awareness Month, we chat with 2 members of our colorectal cancer guideline committee. We're joined by Justin Davies, a consultant colorectal surgeon, and Julie Hepburn, a patient who has had colorectal cancer. They discuss the warning signs and symptoms, available treatments and their involvement in guideline development.

Bowel cancer - warning signs and symptoms

Following Mental Health Awareness Week, we hear about 4 NICE-approved digital technologies that can help children and young people with mild to moderate symptoms of anxiety or low mood. Our guests are Sarah Byron, NICE's programme director for devices, diagnostics and digital, and Lily Tang, deputy director of digital investment strategy at NHS England.

Digital therapies to treat mental health conditions

We speak with Meindert Boysen, NICE's head of international affairs, and Dr Nicole Mittmann, vice president of scientific evidence, methodologies and resources at CADTH - Canada's drug and health technology agency. They discuss the global partnerships that are enabling NICE to remain at the forefront of guidance development methodology.

Our international partnerships - working collaboratively for the benefit of patients

We’re making some changes to how we evaluate medicines to help get new treatments to patients quicker. In this month's podcast, we hear from Jenniffer Prescott, programme director within NICE's Centre for Health Technology Evaluation and Victoria Jordan from The Association of the British Pharmaceutical Industry about our new approach.

Our proportionate approach to technology appraisals

More than 10,000 virtual ward beds will be used by the NHS in England this winter to care for people with an acute respiratory infections.

To learn more about the benefits and opportunities of introducing a virtual ward, or hospital at home service, our guests are Mark Salmon, programme director in the Science, Evidence, and Analytics Directorate at NICE and Becky Housley, consultant nurse at Hampshire Hospitals NHS Foundation Trust, with responsibility for the virtual health hub.

Our guidance on virtual wards (hospital at home) services

Following the publication of our new guideline, ovarian cancer: identifying and managing familial and genetic risk, the latest episode of NICETalks focuses on genetic testing and how it can help to identify those most at risk of ovarian cancer. 

We talk to Ranjit Manchanda, professor of gynaecological oncology, Queen Mary University of London and Barts Health NHS Trust, Dr Judith Hayward, GP with special interest in genetics and Joanne Stanford who joined us to share her personal experience of genetic testing.

Assessing the familial and genetic risk of ovarian cancer

We're joined by Mark Chapman, director of NICE's HealthTech programme and Verena Stocker, director of Innovation, Research, Life Sciences and Strategy at NHS England to discuss the benefits and opportunities the proposed pathway will offer.

Take part in the consultation: https://www.engage.england.nhs.uk/specialised-commissioning/building-an-integrated-rules-based-medtech-pathway/

Learn more about the NICE and NHS England MedTech Pathway consultation

The National Institute for Health and Care Excellence has, for the first time, published a guideline on the identification and management of adrenal insufficiency, a rare condition which occurs when the adrenal glands do not produce enough essential hormones – particularly cortisol and aldosterone.
We're joined by Dr Helen Simpson, a consultant endocrinologist at UCLH NHS Foundation Trust and Sally Tollerfield an endocrine clinical nurse specialist at Great Ormond Street Hospital, to discuss the guideline and the benefits it will provide to patients and healthcare professionals.

Learn more about NICE's new guideline on identifying and managing adrenal insufficiency

In this episode we’re going to be learning about the role of NICE's independent advisory committees. How they operate, who are the members and what flexibility they have in deciding what medicines should be made available to NHS patients in England.

Our guests are NICE's director of medicines evaluation Helen Knight and Professor Steve O'Brien, one of our independent advisory committee chairman.

Learn about the role of NICE's independent advisory committees

In this episode we’re going to be learning about the updated NICE guideline on the identification and management of the menopause.

Our guests are Marie Anne Ledingham, a Consultant Clinical Adviser at NICE and an NHS obstetrician and gynecologist. 

And Professor Martha Hickey, consultant in Gynaecology at the Royal Women’s Hospital, Victoria, Australia and topic advisor on the NICE guideline committee.

Learn more about the guideline here:

And the discussion aid here:

Learn more about NICE's updated menopause guideline

In this episode we discuss our consultation on NICE's routing criteria for highly specialised technologies. 

Professor Jonathan Benger, our deputy chief executive and chief medical officer, outlines the proposals.

Visit the consultation page to have your say: https://www.nice.org.uk/guidance/indevelopment/GID-PMG10008/consultation/html-content

The consultation is open from Thursday 19 December 2024 and will run until Thursday 30 January 2025.

Learn more about the proposed changes to our routing criteria for highly specialised technologies

We're joined by Jules Fielder, who was diagnosed with stage 4 lung cancer in 2021, Dr Jesme Fox, medical director of the Roy Castle Lung Cancer Foundation, Dr Tom Newsom-Davis, consultant medical oncologist at Chelsea and Westminster Hospital, and Chair-Elect of the British Thoracic Oncology Group, and Dr Lynn Campbell, consultant medical oncologist at Belfast City Hospital and committee member for the NICE lung cancer guidelines.

NICE's positive recommendations for lung cancer treatments

In this episode we’re going to be learning about how NICE is preparing to use artificial intelligence.
 
Dr Pall Jonsson, programme director for data and real-world evidence at NICE and Dr Stephen Duffield, associate director for real-world evidence at NICE discuss the impact of this dynamic and rapidly advancing field.

Find out more about NICE's work in AI and watch our recent webinar at: https://www.nice.org.uk/about/what-we-do/digital-health/artificial-intelligence-at-nice

Navigating the future - AI at NICE

To mark endometriosis awareness month this March we discuss the global initiative, Endometriosis Explained, aiming to educate and support those affected by this condition.
In this episode, we're joined by Emma Cox, CEO of Endometriosis UK and gynaecologist Christian Becker from the University of Oxford. 
Find our guideline here: https://www.nice.org.uk/guidance/ng73
And our quality standard here: https://www.nice.org.uk/guidance/qs172

Endometriosis - learn more about NICE's guideline for this chronic condition

In this episode we’re going to be learning more about NICE's guidance for robotic assisted surgery. 

Our guests are Dr Anastasia Chalkidou, NICE’s HealthTech programme director. 

And John McGrath, consultant urologist at North Bristol NHS Trust, and chair of the NHSE Steering Committee for Robotic Assisted Surgery.

Learn more about NICE's guidance for:

Robotic-assisted surgery for soft tissue procedures: https://www.nice.org.uk/guidance/HTE21

Robotic-assisted surgery for orthopaedic procedures:
https://www.nice.org.uk/guidance/HTE22

Will robotic-assisted surgery change NHS practice forever?

We're joined by health visitor Karen McLean and health psychologist Vivien Swanson, two members of the guideline committee, to discuss the changes made to the updated guideline to support nutrition and weight management in pregnancy, and nutrition in children up to 5 years.

Find the guideline here: www.nice.org.uk/guidance/NG247

Learn more about our useful and useable maternal and child nutrition guideline

NICE's prioritisation board has been in operation for just over 12 months. In this episode we review the first year and learn more about how decisions are made, incorporating the role of the patient voice. Our guests are Kay Nolan, head of prioritisation and surveillance at NICE, and Carole Pitkeathley, a lay member of NICE’s prioritisation board.

NICE's prioritisation board: focus on what matters most

Our Health Technology Assessment Innovation Laboratory (HTA Lab) was launched in June 2023 to test and develop creative solutions to complex problems in health technology assessment.

Joining us to discuss its first 2 years of success are our guests: Jamie Elvidge, senior scientific adviser at NICE; Jack Turner, deputy director for medicines access at NHS England; and Victoria Jordan, director of value and access policy at the Association of the British Pharmaceutical Industry. 

Innovation in action: Inside NICE's HTA Lab

In this episode, we discuss recent analysis showing significant disparities in SGLT-2 inhibitor prescriptions for people with type 2 diabetes in England.

We also explore how our new draft recommendations for these medications could increase uptake with our three guests.

They are: Dr Waqaar Shah, chair of the type 2 diabetes guideline committee; Dr Soon Song, consultant physician and diabetologist at Sheffield Teaching Hospitals NHS Foundation Trust; Dr Rahul Mohan, a GP and secretary of the Primary Care Diabetes Society.

Learn more about: www.nice.org.uk/news/articles/wom…r-type-2-diabetes

Read our draft guideline for type 2 diabetes medicines management: www.nice.org.uk/guidance/gid-ng10336/documents/450

Treating type 2 diabetes with SGLT-2 inhibitors

In this episode we learn how NICE is helping to deliver the government's 10 year health plan. Our guests are the senior responsible officers looking after the three  NICE projects. They are: associate director for planning and operations Jenna Dilkes; deputy director for HealthTech Sarah Byron; anddeputy director for medicines evaluation Jac Bouvy.

How NICE is helping to deliver the government's 10 year health plan

We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway.

Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4

Getting medicines to NHS patients faster with aligned decisions with the MHRA

There are now a greater proportion of people living longer with more health conditions and taking new combinations of medicines. How can we adjust medical practice to deal with this? Professor David Haslam, Chair of NICE, explains why we need to address multimorbidity and how we are moving forward to overcome the challenges. Emily gives her personal experiences of managing multiple conditions and Dr James Larcombe explains how GPs deal with these complex situations on the field.

Full NICE guidance: https://www.nice.org.uk/guidance/ng56

Managing multimorbidity: putting patients at the heart of their care

Listen to Professor Mathew Thomson, a researcher from the People’s History of the NHS research group, Paul Farmer CEO of MIND and Sir David Haslam, Chair of NICE discuss how mental healthcare has changed. What could the future hold?

NHS 70TH SPECIAL: How has mental healthcare changed over the last 70 years?

How much does family history affect the chances of being diagnosed with breast cancer and what are the early warning signs? We speak to Professor Andrew Wardley, Breast Cancer Medical Oncologist at The Christie Hospital, Manchester, and Geneva Rhodes, a current patient at The Christie and patient advocate.

Breast Cancer: The significance of family history and looking for early warning signs

As 2020 comes to a close, we’re taking a look back at our biggest challenges and achievements this year, and what we’re most looking forward to in the years ahead. 

In this episode we speak with Professor Gillian Leng, our chief executive, and our new chairman, Sharmila Nebhrajani, OBE, as they reflect on 2020 and look forward to the years ahead.

2020 - A Year in Review

NICE Talks is the podcast from UK's National Institute of Health and Care Excellence (NICE). Our podcast brings the stories behind our NICE's work to improve outcomes for people using the NHS and other public health and social care services through evidence-based guidance.

Subscribe on your favourite podcast platform: https://linktr.ee/nicetalks

NICE Talks

Pinned to spotlight

Popular tracks